Page 500 - ACCCN's Critical Care Nursing

Neurological Alterations and Management 477

62. Australian Institute of Health and Welfare (AIHW). Health and welfare of 87. Benejam B, Sahuquillo J, Poca MA, Frascheri L, Solana E et al. Quality of life
Australia’s Aboriginal and Torres Strait Islander peoples. AIHW cat. no. IHW-14; and neurobehavioral changes in survivors of malignant middle cerebral
Canberra: AIHW; 2005. artery infarction. Neurol 2009; 256(7): 1126–33.
63. Bradley C, Harrison JE. Injury risk factors, attitudes and awareness. Submission 88. Runchey S, McGee S. Does this patient have a hemorrhagic stroke? Clinical
to the CATI-TRG. Injury Technical Paper Series no. 3. AIHW cat. no. INJCAT findings distinguishing hemorrhagic stroke from ischemic stroke. JAMA
61. Adelaide: AIHW; 2003. 2010; 303(22): 2280–86.
64. Myburgh JA, Cooper DJ, Finfer SR, Venkatesh B, Jones D et al. Epidemiology 89. Oliveria-Filho J, Koroshetz WJ. Hemorrhagic stroke. In: O’Donnell J, Nácul
and 12-month outcomes from traumatic brain injury in Australia and New FE eds. Surgical intensive care medicine. New York: Springer; 2010.
Zealand. J Trauma-Injury Infect Crit Care 2008; 64(4): 854–62. 90. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S et al. Efficacy and safety
65. Luukinen H, Viramo P, Herala M, Kervinen K, Kesaniemi YA et al. Fall-related of recombinant activated factor VII for acute intracerebral hemorrhage.
brain injuries and the risk of dementia in elderly people: a population-based N Engl J Med 2008; 358(20): 2127–37.
study. Eur J Neurol 2005; 12(2): 86–92. 91. Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different compo-
66. Keenan HT, Runyan DK, Marshall SW, Nocera MA, Merten DF. A population- nents of triple-H therapy on cerebral perfusion in patients with aneurysmal
based comparison of clinical and outcome characteristics of young children subarachnoid haemorrhage: a systematic review. Crit Care 2010; 14(1): R23.
with serious inflicted and noninflicted traumatic brain injury. Pediatrics 92. Jost SC, Diringer MN, Zazulia AR, Videen TO et al. Effect of normal saline
2004; 114(3): 633–9. bolus on cerebral blood flow in regions with low baseline flow in patients
67. Gaetz M. The neurophysiology of brain injury. Clin Neurophysiol 2004; with vasospasm following subarachnoid haemorrhage. J Neurosurg 2005;
115(1): 4–18. 103(1): 25–30.
68. Soustiel JF, Sviri GE, Mahamid E, Shik V, Abeshaus S, Zaaroor M. Cerebral 93. Hinson HE, Hanley DF, Ziai WC. Management of intraventricular hemor-
blood flow and metabolism following decompressive craniectomy for rhage. Curr Neurol Neurosci Rep 2010; 10(2): 73–82.
control of increased intracranial pressure. Neurosurgery 2010; 67(1): 94. Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE et al. Guidelines
65–72. for the management of aneurysmal subarachnoid hemorrhage: a statement
69. Badruddin A, Taqi MA, Abraham MG, Dani D, Zaidat OO. Neurocritical care for healthcare professionals from a special writing group of the Stroke
of a reperfused brain. Curr Neurol Neurosci 2011; 11(1):104–10. Council, American Heart Association. Stroke 2009; 40(3): 994–1025.
70. Hendricks HT, Heeren AH, Vos PE. Dysautonomia after severe traumatic 95. Coghlan LA, Hindman BJ, Bayman EO, Banki NM, Gelb AW et al. Indepen-
brain injury. Eur J Neurol 2010; 17(9): 1172–7. dent associations between electrocardiographic abnormalities and outcomes
71. Andriessen TM, Jacobs B, Vos PE. Clinical characteristics and pathophysio- in patients with aneurysmal subarachnoid hemorrhage: findings from the
logical mechanisms of focal and diffuse traumatic brain injury. J Cell Mol intraoperative hypothermia aneurysm surgery trial. Stroke 2009; 40(2):
Med 2010; 14(10): 2381–92. 412–18.
72. SAFE Study Investigators; Australian and New Zealand Intensive Care Society 96. Agostoni E, Aliprandi A, Longoni M. Cerebral venous thrombosis. Expert Rev
Clinical Trials Group; Australian Red Cross Blood Service; George Institute Neurother 2009; 9(4): 553–64.
for International Health, Myburgh J et al. Saline or albumin for fluid resus- 97. Huppatz C, Kelly PM, Levi C, Dalton C, Williams D, Durrheim DN. Enceph-
citation in patients with traumatic brain injury. N Engl J Med 2007; 357(9): alitis in Australia, 1979–2006: trends and aetiologies. Commun Dis Intell
874–84. 2009; 33(2): 192–7.
73. Jagoda AS. Mild traumatic brain injury: key decisions in acute management. 98. Martin D, Lopez L. The epidemiology of meningococcal disease in New
Psychiatr Clin North Am 2010; 33(4): 797–806. Zealand in 2009. [Cited December 2010]. Available from: http://
74. Donovan D. Simple depressed skull fracture causing sagittal sinus stenosis www.surv.esr.cri.nz/PDF_surveillance/MeningococcalDisease/2009/
and increased intracranial pressure: case report and review of the literature. 2009AnnualRpt.pdff.
Surg Neurol 2005; 63(4): 380–83. 99. Communicable Diseases Network Australia, Meningococcal Disease Sub-
75. Norton L. Spinal cord injury, Australia 2007–08. Injury research and statistics Committee. Guidelines for the early clinical and public health management
series no. 52. Cat. no. INJCAT 128. Canberra: AIHW; 2010. of meningococcal disease in Australia 2007. [Cited December 2010]. Avail-
76. Russ SA, Hancock SW, Quinton M, Moore R, Harrison P. Patterns and risks able from: http://www.health.gov.au/internet/main/publishing.nsf/content/
in spinal trauma: the emergency transport perspective. Arch Dis Child 2005; BC329B583B663546CA25736D007674AA/$File/meningococcal-
90(9): 985. guidelines.pdf.
77. Robertson A, Branfoot T, Barlow I, Giannoudis P. Spinal injury patterns 100. Markey PG, Davis JS, Harnett GB, Williams SH, Speers DJ. Meningitis and a
resulting from car and motorcycle accidents. Spine 2002; 27(24): febrile vomiting illness caused by echovirus type 4, northern territory, Aus-
2825–30. tralia. Emerg Infect Dis 2010; 16(1): 63–8.
78. Gala V, Voyadzis JM, Kim D, Asir A, Fessler RG. Trauma of the nervous 101. Huppatz C, Durrheim DN, Levi C, Dalton C, Williams D et al. Etiology
system, spinal cord trauma. In: Bradley W, Daroff D, Fenichel D, Jankovic J of encephalitis in Australia, 1990–2007. Emerg Infect Dis 2009; 15(9):
(eds). Neurology in clinical practice, 5th edn. Philadelphia: Butterworth-Heine- 135–65.
mann Elsevier; 2008. 102. Wilder-Smith A, Halstead S. Japanese encephalitis: Update on vaccines and
79. Sheerin F. Spinal cord injury: causation and pathophysiology. Emerg Nurse vaccine recommendations. Curr Opin Infect Dis 2010; 23(5): 426–31.
2005; 12(9): 29–38. 103. Playford EG, McCall B, Smith G, Slinko V, Allen G et al. Human hendra virus
80. Pimentel L, Diegelmann L. Evaluation and management of acute cervical encephalitis associated with equine outbreak, Australia, 2008. Emerg Infect
spine trauma. Emerg Med Clin North Am 2010; 28(4): 719–38. Dis 2010; 16(2): 219–23.
81. Ahn H, Singh J, Nathens A, Macdonald RD, Travers A, Tallon J, Fehlings M, 104. Einsiedel L, Kat E, Ravindran J, Slavotinek J, Gordon DL. MR findings in
Yee A. Pre-hospital care management of a potential spinal cord injured Murray Valley encephalitis. Am J Neuroradiol 2003; 24(7): 1379–82.
patient: a systematic review of the literature and evidence-based guidelines. 105. Douglas MW, Stephens DP, Burrow JNC, Anstey NM, Talbot K, Currie BJ.
J Neurotrauma 2011. In press. Murray valley encephalitis in an adult traveller complicated by long-term
82. Gupta R, Bathen ME, Smith JS, Levi AD, Bhatia NN, Steward OJ. Advances flaccid paralysis: Case report and review of the literature. Trans R Soc Trop
in the management of spinal cord injury. Am Acad Orthop Surg 2010; 18(4): Med Hyg 2007; 101(3): 284–8.
210–22. 106. Roberts JA, Grant KA, Yoon YK, Polychronopoulos S, Ibrahim A, Thorley BR.
83. Hawryluk GW, Rowland J, Kwon BK, Fehlings MG. Protection and repair of Annual report of the Australian national poliovirus reference laboratory,
the injured spinal cord: a review of completed, ongoing, and planned 2008. Commun Dis Intell 2009; 33(3): 291–7.
clinical trials for acute spinal cord injury. Neurosurg Focus 2008; 25(5): 107. Sederholm BH. Treatment of acute immune-mediated neuropathies: Guil-
E14. lain–Barré syndrome and clinical variants. Semin Neurol 2010; 30(4):
84. Godoy DA, Di Napoli M, Rabinstein AA. Treating hyperglycemia in 365–72.
neurocritical patients: benefits and perils. Neurocrit Care 2010; 13(3): 108. Fergusson D, Hutton B, Sharma M, Tinmouth A, Kumanan Wilson D et al.
425–38. Use of intravenous immunoglobulin for treatment of neurologic conditions:
85. Australian Institute of Health and Welfare. Cardiovascular disease mortality: a systematic review. Transfusion 2005; 45(10): 1640–57.
trends at different ages. Cardiovascular series no. 31. Cat. no.47. Canberra: 109. Orlikowski D, Prigent H, Sharshar T, Lofaso F, Raphael JC. Respiratory dys-
AIHW; 2010. function in Guillain–Barré syndrome. Neurocrit Care 2004; 1(4): 415–22.
86. Stroke Foundation of New Zealand and New Zealand Guidelines Group. 110. Ruts L, Drenthen J, Jongen JLM, Hop WCJ, Visser GH et al. Pain in
Clinical Guidelines for Stroke Management 2010. Wellington: Stroke Founda- Guillain–Barré syndrome: A long-term follow-up study. Neurology 2010;
tion of New Zealand; 2010. 75(16): 1439–47